Back

Welcome

31 August 2025 (15:15 - 15:17)
Organised by: Logo
Congress Presentation Part of: A new way to treat pulmonary arterial hypertension (PAH) that improves hemodynamics and right ventricular function Treatment Open Access ESC Congress 2025 European Society of Cardiology

5 More presentations in this session

Presentation thumbnail
Right ventricular (RV) function assessment in PAH: why do we care?
Professor V. Moles (Ann Arbor, US)
Presentation thumbnail
A new pathway to treat PAH targeted by the first activin signaling inhibitor (ASI)
Doctor M. Escribano Subias (Madrid, ES)
Presentation thumbnail
Clinical data into context: effect of sotatercept on right ventricular (RV) function and structure
Doctor A. Vaidya (Temple, US)
Presentation thumbnail
Considerations on clinical implications
Professor S. Rosenkranz (Cologne, DE)
Presentation thumbnail
Q&A
Professor S. Rosenkranz (Cologne, DE)

Access the full session

Session thumbnail
A new way to treat pulmonary arterial hypertension (PAH) that improves hemodynamics and right ventricular function
Video

The Event

Event poster

ESC Congress 2025

31 August 2025 15:15 CET
You may be interested in
thumbnail
Congress Presentation
Conclusion & closing.
28 August 2022
thumbnail
Congress Presentation
One medical device regulation, many country interpretations: lessons learned from EHRA-PATHS software tool use in a clinical trial
14 April 2026
thumbnail
Webinar
Shared decision-making in cardiology care: what is it and do we really do it? Making every contact count!
14 September 2021
thumbnail
Webinar
Nonsteroidal MRAs and heart failure: interpretation and impact on practice - which patients should be receiving MRAs?
21 July 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources